New hope for Hard-to-Treat prostate cancer: early trial launched
NCT ID NCT04428788
First seen Jan 10, 2026 · Last updated May 22, 2026 · Updated 21 times
Summary
This early-phase study tested a new drug called CC-94676 in 131 men with advanced prostate cancer that had spread and stopped responding to standard hormone treatments. The main goals were to check the drug's safety, find the right dose, and see if it could help control the cancer. While not a cure, the study aimed to offer a new option for managing this aggressive disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATIC NEOPLASMS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Local Institution - 101
San Antonio, Texas, 78229, United States
-
Local Institution - 102
Grand Rapids, Michigan, 49546, United States
-
Local Institution - 103
Sarasota, Florida, 34232, United States
-
Local Institution - 104
Boston, Massachusetts, 02215, United States
-
Local Institution - 105
New York, New York, 10065, United States
-
Local Institution - 106
Durham, North Carolina, 27710, United States
-
Local Institution - 107
Dallas, Texas, 75235, United States
-
Local Institution - 108
Baltimore, Maryland, 21287, United States
-
Local Institution - 109
New York, New York, 10032, United States
-
Local Institution - 111
Madison, Wisconsin, 53792, United States
-
Local Institution - 112
New York, New York, 10029, United States
-
Local Institution - 113
Philadelphia, Pennsylvania, 19104, United States
-
Local Institution - 115
Seattle, Washington, 98109, United States
-
Local Institution - 116
Stanford, California, 94305-5826, United States
-
Local Institution - 117
Ann Arbor, Michigan, 48109, United States
-
Local Institution - 119
Houston, Texas, 77030, United States
-
Local Institution - 120
Allentown, Pennsylvania, 18103, United States
-
Local Institution - 121
Thomasville, Georgia, 31792, United States
-
Local Institution - 122
Washington D.C., District of Columbia, 20010, United States
Conditions
Explore the condition pages connected to this study.